Detalles de la búsqueda
1.
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Breast Cancer Res
; 25(1): 62, 2023 06 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37280713
2.
Limb expression 1-like protein promotes epithelial-mesenchymal transition and epidermal growth factor receptor-tyrosine kinase inhibitor resistance via nucleolin-mediated ribosomal RNA synthesis in non-small cell lung cancer.
Cancer Sci
; 114(4): 1740-1756, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36478492
3.
ETV4 overexpression promotes progression of non-small cell lung cancer by upregulating PXN and MMP1 transcriptionally.
Mol Carcinog
; 59(1): 73-86, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31670855
4.
Personal Evolution in Thighplasty Techniques for Patients Following Massive Weight Loss.
Aesthet Surg J
; 37(10): 1124-1135, 2017 Oct 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-29044362
5.
Targeting CXCR4 abrogates resistance to trastuzumab by blocking cell cycle progression and synergizes with docetaxel in breast cancer treatment.
Res Sq
; 2023 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36824840
6.
HDAC6-G3BP2 promotes lysosomal-TSC2 and suppresses mTORC1 under ETV4 targeting-induced low-lactate stress in non-small cell lung cancer.
Oncogene
; 42(15): 1181-1195, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36823378
7.
High mobility group box-1 protects against Aflatoxin G1-induced pulmonary epithelial cell damage in the lung inflammatory environment.
Toxicol Lett
; 331: 92-101, 2020 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32446815
8.
Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors.
Oncotarget
; 5(18): 8544-57, 2014 Sep 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-25261369
Resultados
1 -
8
de 8
1
Próxima >
>>